A prospective study of venous thromboembolism in relation to factor V Leiden and related factors
Open accessThe DOI matches its Crossref record.
Abstract
The aim of this study was to examine the occurrence of venous thromboembolism (VTE) in relation to factor V–related risk factors. Using a nested case-control design combining 2 population-based prospective studies, we measured factor V Leiden, HR2 haplotype, activated protein C (APC) resistance, and plasma factor V antigen in 335 participants who developed VTE during 8 years of follow-up and 688 controls. The overall odds ratio (OR) of VTE was 3.67 (95% CI, 2.20-6.12) in participants carrying factor V Leiden compared with noncarriers. APC resistance measured after predilution with factor V–deficient plasma conferred an OR of 2.58 (95% CI, 1.62-4.10). All 3 participants homozygous for the HR2 haplotype had a VTE, and the OR of VTE for homozygosity was estimated to be 5.5 (95% CI, 2.45-12.5). Carriers of the HR2 haplotype otherwise were not at increased risk of VTE overall (OR = 1.05; 95% CI, 0.64-1.72), but double heterozygotes for HR2 and factor V Leiden carried an OR of idiopathic VTE of 16.3 (95% CI, 1.7-159) compared with noncarriers. Factor V antigen also was not associated with VTE overall, but for participants with the combination of high factor V antigen plus factor V Leiden the OR of idiopathic VTE was 11.5 (95% CI, 4.2-31.4). In the general population, APC resistance and factor V Leiden were important VTE risk factors; homozygosity for the HR2 haplotype may be a risk factor but was rare; otherwise, HR2 haplotype and factor V antigen were not risk factors except in carriers of factor V Leiden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Epidemiology of venous thromboembolism
Heit, J. A. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.83 · Cited by 1,277
Epidemiology and Risk Factors for Venous Thrombosis
Cushman, M. (2007) · Seminars in Hematology · doi:10.1053/j.seminhematol.2007.02.004 · Cited by 755
Self-citationVenous thromboembolism: disease burden, outcomes and risk factors
HEIT, J. A. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01415.x · Cited by 447
Heit, J. A. (2006) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-006-5572-y · Cited by 383
Simone, B., De Stefano, V., Leoncini, E., Zacho, J., Martinelli, I., Emmerich, J., Rossi, E., Folsom, A. R., Almawi, W. Y., Scarabin, P. Y., et al. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9825-8 · Cited by 207
“28 databases out of 37 (76 %) came from European countries [9, 16, 19, 20, 23– 26, 29–37, 39–43, 45], 3 from Latin America [9, 21, 44], 4 from North America [22, 27, 28, 38] and 2 from Asia [17, 18].”
Self-citation
Metadata
- Authors
- Folsom, A. R., Cushman, M., Tsai, M. Y., Aleksic, N., Heckbert, S. R., Boland, L. L., Tsai, A. W., Yanez, N. D., & Rosamond, W. D.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-04-15
- Volume
- 99
- Issue
- 8
- Pages
- 2720-2725
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2077676515
- Cited by
- 141
- References
- 0
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. https://app.cochat.ai/papers/10.1182/blood.v99.8.2720
- The paper
- Folsom, A. R., Cushman, M., Tsai, M. Y., Aleksic, N., Heckbert, S. R., Boland, L. L., Tsai, A. W., Yanez, N. D., & Rosamond, W. D. (2002). A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood. https://doi.org/10.1182/blood.v99.8.2720
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.